Back to search

Spain· ES:114982001

Viekirax 12,5 mg/ 75 mg/ 50 mg comprimidos recubiertos con pelicula

A ombitasvir, paritaprevir and ritonavir product containing ombitasvir + paritaprevir + ritonavir, registered in Spain by Abbvie Deutschland Gmbh & Co. Kg. The same ATC class is registered in 6 of our 19 countries.

ATC J05AP53

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedViekirax 12,5 mg/ 75 mg/ 50 mg compri…ATCJ05AP53REGISTER NO.ES:114982001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Ombitasvir, paritaprevir and ritonavir is registered in 6 of 19 countries.

Countries holding a registration under ATC J05AP53 (ombitasvir, paritaprevir and ritonavir), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 4 of them publish a price we can compare per daily dose

Ombitasvir, paritaprevir and ritonavir · ATC J05AP53

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AEMPS CIMA (Spain)
Active substance
ombitasvir + paritaprevir + ritonavir
Manufacturer
Abbvie Deutschland Gmbh & Co. Kg
Country
Spain (ES)
ATC code
J05AP53
ATC class
Ombitasvir, paritaprevir and ritonavir
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ombitasvir, paritaprevir and ritonavir in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ombitasvir, paritaprevir and ritonavir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb938c9d-12c5-4951-85c6-da3f0b56725f
GET /v1/drugs/fb938c9d-12c5-4951-85c6-da3f0b56725f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Diagnóstico Hospitalario",
  "estado": "{\"aut\":1422969855000,\"rev\":1732265112000}",
  "nregistro": "114982001",
  "substance": "ombitasvir + paritaprevir + ritonavir"
}

See everything about ombitasvir, paritaprevir and ritonavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.